Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Aggressiveness”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableLooking for participantsNCT07052578
What this trial is testing

Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

Who this might be right for
Prostate Cancer
AstraZeneca 400
Not applicableStudy completedNCT02453139
What this trial is testing

Exercise, Prostate Cancer and Circulating Tumour Cells

Who this might be right for
Prostate CancerObesity
University of Dublin, Trinity College 67
Early research (Phase 1)Active Not RecruitingNCT04388852
What this trial is testing

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+7 more
M.D. Anderson Cancer Center 65
Not applicableActive Not RecruitingNCT01464216
What this trial is testing

MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness

Who this might be right for
Prostatic NeoplasmsGenital Neoplasms, MaleProstatic Diseases
Oslo University Hospital 120
Not applicableStudy completedNCT03911999
What this trial is testing

Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese Patients

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 180
Not applicableLooking for participantsNCT04052048
What this trial is testing

Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

Who this might be right for
Prostate Cancer Aggressiveness
Immunis.AI 2,000
Testing effectiveness (Phase 2)Study completedNCT05005728
What this trial is testing

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Xencor, Inc. 72
Large-scale testing (Phase 3)Not Yet RecruitingNCT05232578
What this trial is testing

Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness

Who this might be right for
Prostate Cancer
General University Hospital, Prague 380
Not applicableTemporarily pausedNCT05064111
What this trial is testing

Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Arizona 100
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Study completedNCT03263650
What this trial is testing

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Who this might be right for
Prostate Cancer AggressivenessProstate Carcinoma
M.D. Anderson Cancer Center 96
Not applicableStudy completedNCT06773858
What this trial is testing

Genetic Studies of Prostate Cancer Aggressiveness and Prognosis

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Cancer After a Radical Treatment
Karolinska Institutet 2,291
Testing effectiveness (Phase 2)Active Not RecruitingNCT03809000
What this trial is testing

Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

Who this might be right for
Prostate Cancer
RTOG Foundation, Inc. 188
Not applicableStudy completedNCT01672411
What this trial is testing

Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer

Who this might be right for
Prostate Cancer
University Of Perugia 250
Not applicableActive Not RecruitingNCT01514669
What this trial is testing

Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer

Who this might be right for
Prostate Cancer
University of Arkansas 75
Testing effectiveness (Phase 2)Looking for participantsNCT06738303
What this trial is testing

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Case Comprehensive Cancer Center 44
Not applicableStudy completedNCT02485379
What this trial is testing

Assessment of Prostate MRI Before Prostate Biopsies

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 275
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Very early researchStudy completedNCT02139371
What this trial is testing

Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography

Who this might be right for
Breast CancerProstate CancerUrinary Bladder Cancer
Rigshospitalet, Denmark 10
Not applicableStudy completedNCT02451345
What this trial is testing

Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model

Who this might be right for
Prostate Cancer
University of California, San Francisco 58
Next Page